Chang-Meng Wu

418 total citations
13 papers, 323 citations indexed

About

Chang-Meng Wu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Chang-Meng Wu has authored 13 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Chang-Meng Wu's work include interferon and immune responses (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Inflammasome and immune disorders (3 papers). Chang-Meng Wu is often cited by papers focused on interferon and immune responses (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Inflammasome and immune disorders (3 papers). Chang-Meng Wu collaborates with scholars based in China, Singapore and Hong Kong. Chang-Meng Wu's co-authors include Lei Zheng, Yan‐Wei Hu, Ruyi Zhang, Qian Wang, Xin He, Limin Li, Limei Wu, Xiumei Hu, Zhifeng Lu and Qian Wu and has published in prestigious journals such as ACS Nano, Biochemical and Biophysical Research Communications and Analytica Chimica Acta.

In The Last Decade

Chang-Meng Wu

12 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang-Meng Wu China 10 180 80 74 54 43 13 323
Hongwang Cui China 11 189 1.1× 61 0.8× 23 0.3× 76 1.4× 35 0.8× 19 343
He Zha China 13 330 1.8× 74 0.9× 184 2.5× 36 0.7× 9 0.2× 21 471
Yanhong Ma China 10 132 0.7× 33 0.4× 27 0.4× 35 0.6× 24 0.6× 26 298
Shujuan Zhou China 13 88 0.5× 39 0.5× 53 0.7× 37 0.7× 27 0.6× 37 369
Magnus Althage Sweden 11 204 1.1× 26 0.3× 27 0.4× 30 0.6× 20 0.5× 23 371
Wang Gong China 7 328 1.8× 75 0.9× 124 1.7× 29 0.5× 9 0.2× 13 477
Xiumeng Hua China 13 253 1.4× 172 2.1× 56 0.8× 39 0.7× 18 0.4× 38 525
Ruhao Yang China 8 135 0.8× 66 0.8× 48 0.6× 16 0.3× 12 0.3× 15 374
Xundou Li China 13 244 1.4× 45 0.6× 24 0.3× 68 1.3× 9 0.2× 27 420

Countries citing papers authored by Chang-Meng Wu

Since Specialization
Citations

This map shows the geographic impact of Chang-Meng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang-Meng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang-Meng Wu more than expected).

Fields of papers citing papers by Chang-Meng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang-Meng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang-Meng Wu. The network helps show where Chang-Meng Wu may publish in the future.

Co-authorship network of co-authors of Chang-Meng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chang-Meng Wu. A scholar is included among the top collaborators of Chang-Meng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang-Meng Wu. Chang-Meng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Zhang, Ruyi, et al.. (2025). UGP2, a novel target gene of TP53, inhibits endothelial cells apoptosis and atherosclerosis. Life Sciences. 363. 123393–123393. 2 indexed citations
3.
Zhang, Ruyi, Fan Bu, Yubing Wang, et al.. (2023). LncRNA RP4-639F20.1 interacts with THRAP3 to attenuate atherosclerosis by regulating c-FOS in vascular smooth muscle cells proliferation and migration. Atherosclerosis. 379. 117183–117183. 4 indexed citations
4.
Zou, Hang, Jing Zhang, Chang-Meng Wu, et al.. (2021). Making Aggregation-Induced Emission Luminogen More Valuable by Gold: Enhancing Anticancer Efficacy by Suppressing Thioredoxin Reductase Activity. ACS Nano. 15(5). 9176–9185. 49 indexed citations
5.
Zhang, Ruyi, Shihua Luo, Xiumei Hu, et al.. (2021). A novel electrochemical biosensor for exosomal microRNA-181 detection based on a catalytic hairpin assembly circuit. Analytica Chimica Acta. 1157. 338396–338396. 29 indexed citations
6.
Hu, Xiumei, Chang-Meng Wu, Bo Situ, et al.. (2021). EDTA-K2 Improves the Detection Sensitivity of SARS-CoV-2 IgM and IgG Antibodies by Chelating Colloidal Gold in the Immunochromatographic Assay. International Journal of Nanomedicine. Volume 16. 715–724. 14 indexed citations
7.
Zhang, Ruyi, Chang-Meng Wu, Xiumei Hu, et al.. (2021). LncRNA AC105942.1 Downregulates hnRNPA2/B1 to Attenuate Vascular Smooth Muscle Cells Proliferation. DNA and Cell Biology. 40(5). 652–661. 13 indexed citations
8.
Hu, Xiumei, Ruyi Zhang, Taixue An, et al.. (2020). Impact of heat-inactivation on the detection of SARS-CoV-2 IgM and IgG antibody by ELISA. Clinica Chimica Acta. 509. 288–292. 24 indexed citations
9.
Wu, Qian, Xin He, Limei Wu, et al.. (2020). MLKL Aggravates Ox-LDL-Induced Cell Pyroptosis via Activation of NLRP3 Inflammasome in Human Umbilical Vein Endothelial Cells. Inflammation. 43(6). 2222–2231. 35 indexed citations
10.
Wang, Jiali, Limin Li, Xin He, et al.. (2020). Lipopolysaccharide Promotes Inflammatory Response via Enhancing IFIT1 Expression in Human Umbilical Vein Endothelial Cells. DNA and Cell Biology. 39(7). 1274–1281. 9 indexed citations
11.
Ding, Li, Limin Li, Bing Hu, et al.. (2020). TM4SF19 aggravates LPS-induced attenuation of vascular endothelial cell adherens junctions by suppressing VE-cadherin expression. Biochemical and Biophysical Research Communications. 533(4). 1204–1211. 12 indexed citations
12.
Wu, Chang-Meng, Lei Zheng, Qian Wang, & Yan‐Wei Hu. (2020). The emerging role of cell senescence in atherosclerosis. Clinical Chemistry and Laboratory Medicine (CCLM). 59(1). 27–38. 56 indexed citations
13.
Wu, Limei, Shao-Guo Wu, Qian Wu, et al.. (2019). Atorvastatin inhibits pyroptosis through the lncRNA NEXN-AS1/NEXN pathway in human vascular endothelial cells. Atherosclerosis. 293. 26–34. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026